Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
61.44
-3.22 (-4.98%)
At close: Dec 5, 2025, 4:00 PM EST
62.20
+0.76 (1.24%)
After-hours: Dec 5, 2025, 7:29 PM EST
Arrowhead Pharmaceuticals Market Cap
Arrowhead Pharmaceuticals has a market cap or net worth of $8.34 billion as of December 5, 2025. Its market cap has increased by 252.89% in one year.
Market Cap
8.34B
Enterprise Value
8.16B
1-Year Change
252.89%
Ranking
Category
Stock Price
$61.44
Market Cap Chart
Since January 15, 2004, Arrowhead Pharmaceuticals's market cap has increased from $300.00K to $8.34B, an increase of 2,781,279.75%. That is a compound annual growth rate of 59.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 8.78B | 275.37% |
| Dec 31, 2024 | 2.34B | -28.84% |
| Dec 29, 2023 | 3.29B | -23.54% |
| Dec 30, 2022 | 4.30B | -37.84% |
| Dec 31, 2021 | 6.92B | -11.95% |
| Dec 31, 2020 | 7.86B | 29.67% |
| Dec 31, 2019 | 6.06B | 451.13% |
| Dec 31, 2018 | 1.10B | 299.42% |
| Dec 29, 2017 | 275.20M | 154.58% |
| Dec 30, 2016 | 108.10M | -70.48% |
| Dec 31, 2015 | 366.20M | -9.27% |
| Dec 31, 2014 | 403.60M | -3.88% |
| Dec 31, 2013 | 419.90M | 1,153.43% |
| Dec 31, 2012 | 33.50M | -24.04% |
| Dec 30, 2011 | 44.10M | -31.42% |
| Dec 31, 2010 | 64.30M | 93.09% |
| Dec 31, 2009 | 33.30M | -15.70% |
| Dec 31, 2008 | 39.50M | -72.93% |
| Dec 31, 2007 | 145.90M | -2.60% |
| Dec 29, 2006 | 149.80M | 25.99% |
| Dec 30, 2005 | 118.90M | 101.87% |
| Dec 31, 2004 | 58.90M | 19,533.33% |
View and export this data all the way back to 2004.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |